abrdn Healthcare Investors (HQH) Stock Price, News & Analysis

Company Overview

abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.

The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth. Portfolio managers analyze industry trends, regulatory environments and competitive positioning to identify both established market leaders and emerging names that can benefit from scientific advancements or demographic shifts, such as aging populations and increased global healthcare spending.

Launched in 1980, abrdn Healthcare Investors is managed by abrdn, a global asset management firm with a long track record in sector-focused investing. The fund trades on the New York Stock Exchange under the ticker symbol HQH, providing investors with liquid access to a professionally managed portfolio of healthcare equities. While the fund is headquartered in the United States, its holdings often include companies across developed markets in North America, Europe and Asia, reflecting healthcare’s global nature.

Key Stats

• Today's Range: $16.82 to $16.94
• 50-Day Range: $15.59 to $16.92
• 52-Week Range: $13.77 to $19.05
• Volume: 119,557 shs
• Average Volume: 208,357 shs
• Market Capitalization: $910.81 million
• P/E Ratio: N/A
• Dividend Yield: 10.23%
• Price Target: N/A
• Consensus Rating: N/A

HQH Stock Analysis - Frequently Asked Questions

How have HQH shares performed this year?

abrdn Healthcare Investors' stock was trading at $16.05 at the beginning of 2025. Since then, HQH stock has increased by 5.4% and is now trading at $16.91.

Who are abrdn Healthcare Investors' major shareholders?

abrdn Healthcare Investors' top institutional investors include Raymond James Financial Inc. (2.41%), Penserra Capital Management LLC (1.93%), Advisors Asset Management Inc. (0.65%) and Ameriprise Financial Inc. (0.64%). Insiders that own company stock include Daniel R Omstead, Todd Reit and Rose Dimartino.
View institutional ownership trends.

How do I buy shares of abrdn Healthcare Investors?

Shares of HQH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of abrdn Healthcare Investors own?

Based on aggregate information from My MarketBeat watchlists, some other companies that abrdn Healthcare Investors investors own include Enterprise Products Partners (EPD), Medical Properties Trust (MPW), Energy Transfer (ET), Mplx (MPLX), PIMCO Dynamic Income Fund (PDI), Cohen & Steers Infrastructure Fund (UTF) and Cleveland-Cliffs (CLF).

Company Calendar

• Record date for 6/30 Dividend: 5/22/2025
• Ex-Dividend for 6/30 Dividend: 5/22/2025
• Dividend Payable: 6/30/2025
• Record date for 9/30 Dividend: 8/22/2025
• Ex-Dividend for 9/30 Dividend: 8/22/2025
• Today: 9/22/2025
• Dividend Payable: 9/30/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: FIN - INVEST FUND
• Sub-Industry: Financial Services
• Current Symbol: NYSE:HQH
• CIK: 805267
• Web: www.teklacap.com
• Phone: (617) 772-8500
• Fax: 617-772-8577
• Employees: 147,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $11.71 million
• Price / Sales: 77.59
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 53,862,000
• Free Float: 49,930,000
• Market Cap: $908.22 million
• Optionable: Not Optionable
• Beta: 0.78